Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Seaport Therapeutics, Inc (SPTX) had Normalized Income after Taxes of -74.88M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-74.88M |
|
-- |
|
-- |
|
87.29M |
|
-87.29M |
|
13.19M |
|
-74.11M |
|
-74.11M |
|
-74.88M |
|
-74.88M |
|
-74.88M |
|
|
Normalized Income after Taxes |
-74.88M |
-87.29M |
|
-89.32M |
|
2.37M |
|
2.37M |
|
-31.54 |
|
-31.54 |
|
| Balance Sheet Financials | |
223.23M |
|
0.41M |
|
25.78M |
|
249.01M |
|
12.78M |
|
-- |
|
3.44M |
|
16.23M |
|
-92.55M |
|
232.78M |
|
232.78M |
|
-- |
|
| Cash Flow Statement Financials | |
-77.94M |
|
-184.25M |
|
-0.87M |
|
309.55M |
|
46.50M |
|
-263.06M |
|
6.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.46 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-78.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.91% |
|
-32.17% |
|
-30.07% |
|
-32.17% |
|
-- |
|
-32.98 |
|
-32.83 |
|